Is Link Pharma Chem Ltd debt-free?

Yes, Link Pharma Chem Ltd is debt-free with a debt-to-equity ratio of 0.46.

Home

Link Pharma Chem Ltd

Link Pharma Chem Ltd Financials

Link Pharma Chem Ltd Financial Statement

Link Pharma Chem Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	8.02	6.56	4.78
Operating Expense	7.17	6.67	5.23
Net Profit	0.40	-0.35	-0.67
Net Profit Margin	4.99	-5.34	-14.02
Earning Per Share	0.91	-0.79	-1.50
EBIDTA	0.74	0.06	-0.22
Effective Tax Rate	TBA	-27.27	TBA

Particulars	Jun 2025
Revenue	8.02
Operating Expense	7.17
Net Profit	0.40
Net Profit Margin	4.99
Earning Per Share	0.91
EBIDTA	0.74
Effective Tax Rate	TBA

Link Pharma Chem Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	29.90	38.76	53.56
Operating Expenses Annual	30.55	36.04	50.02
Operating Profit Annual	-0.01	2.57	4.00
Interest Annual	0.87	0.76	0.45
Depreciation	1.03	0.92	0.93
Net Profit Annual	-1.36	0.65	1.88
Tax Annual	-0.55	0.23	0.74

Particulars	Mar 2024
Total Revenue Annual	29.90
Operating Expenses Annual	30.55
Operating Profit Annual	-0.01
Interest Annual	0.87
Depreciation	1.03
Net Profit Annual	-1.36
Tax Annual	-0.55

Link Pharma Chem Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.09	0.27	4.22
Cash Flow from Operations	-0.03	-1.71	-1.26
Cash Flow from Investing	0.41	-0.08	-4.97
Cash Flow from Financing	-0.41	1.61	2.27
Cash Flow at the End	0.06	0.09	0.27

Particulars	Mar 2024
Cash Flow at the Beginning	0.09
Cash Flow from Operations	-0.03
Cash Flow from Investing	0.41
Cash Flow from Financing	-0.41
Cash Flow at the End	0.06

Link Pharma Chem Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	-0.03	6.24	6.29
PBIT Margin (%)	-3.48	3.87	4.56
PBT Margin (%)	0.53	-1.19	-5.56
Net PROFIT Margin (%)	-4.55	1.68	3.51
Return On Networth / Equity (%)	-9.46	3.86	10.65
Return On Networth /Employed (%)	-4.43	6.64	13.09
Return On Assets (%)	-5.78	2.90	10.07
Total Debt / Equity (X)	0.63	0.51	0.37
Asset Turnover Ratio (%)	1.27	1.73	2.87

Particulars	Mar 2024
PBDIT Margin (%)	-0.03
PBIT Margin (%)	-3.48
PBT Margin (%)	0.53
Net PROFIT Margin (%)	-4.55
Return On Networth / Equity (%)	-9.46
Return On Networth /Employed (%)	-4.43
Return On Assets (%)	-5.78
Total Debt / Equity (X)	0.63
Asset Turnover Ratio (%)	1.27

Link Pharma Chem Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	9.94	9.00	8.79
Total Current Assets Annual	11.53	17.55	13.57
Non Current Assets Annual	14.42	14.91	15.39
Total Shareholders Funds Annual	13.71	15.04	14.47
Total Assets Annual	25.95	32.46	28.96

Particulars	Mar 2024
Fixed Assets Annual	9.94
Total Current Assets Annual	11.53
Non Current Assets Annual	14.42
Total Shareholders Funds Annual	13.71
Total Assets Annual	25.95

Link Pharma Chem Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Link Pharma Chem Ltd Financials

As of Aug 7, 2025, Link Pharma Chem Ltd has a market capitalization of 15.01 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Link Pharma Chem Ltd is with a debt-to-equity ratio of 0.46.

In FY 2024 , Link Pharma Chem Ltd recorded a total revenue of approximately 25.43 Cr marking a significant milestone in the company's financial performance.

Link Pharma Chem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and -0.2% annually, respectively..

Link Pharma Chem Ltd's current PE ratio is -14.57.

Link Pharma Chem Ltd's ROCE averaged -0.3% from the FY ending March 2023 to 2025, with a median of -3.4%. It peaked at 6.9% in March 2023, reflecting strong capital efficiency over the period..

Link Pharma Chem Ltd's latest EBIT is Rs. -0.62 Cr, surpassing the average EBIT of Rs. -0.01 Cr over the 5 years..